{"id":"NCT03136484","sponsor":"Novo Nordisk A/S","briefTitle":"Efficacy and Safety of Semaglutide Versus Canagliflozin as add-on to Metformin in Subjects With Type 2 Diabetes","officialTitle":"Efficacy and Safety of Semaglutide Versus Canagliflozin as add-on to Metformin in Subjects With Type 2 Diabetes","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2017-03-15","primaryCompletion":"2018-10-16","completion":"2018-11-16","firstPosted":"2017-05-02","resultsPosted":"2019-12-17","lastUpdate":"2020-01-21"},"enrollment":788,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Diabetes","Diabetes Mellitus, Type 2"],"interventions":[{"type":"DRUG","name":"Semaglutide","otherNames":[]},{"type":"DRUG","name":"Canagliflozin","otherNames":[]},{"type":"DRUG","name":"Placebo (canagliflozin)","otherNames":[]},{"type":"DRUG","name":"Placebo (semaglutide)","otherNames":[]}],"arms":[{"label":"Semaglutide + canagliflozin placebo","type":"EXPERIMENTAL"},{"label":"Canagliflozin + semaglutide placebo","type":"ACTIVE_COMPARATOR"}],"summary":"This trial is conducted in Africa, Asia, Europe, North and South America. The aim of the trial is to compare the effect of once-weekly (OW) dosing of subcutaneous semaglutide (1.0 mg) versus once-daily dosing of oral canagliflozin (300 mg) on glycaemic control in subjects with type 2 diabetes (T2D) on a background treatment of metformin","primaryOutcome":{"measure":"Change in HbA1c","timeFrame":"Week 0, week 52","effectByArm":[{"arm":"Semaglutide + Canagliflozin Placebo","deltaMin":-1.7,"sd":1.1},{"arm":"Canagliflozin + Semaglutide Placebo","deltaMin":-1,"sd":1}],"pValues":[{"comp":"OG000 vs OG001","p":"<.0001"},{"comp":"OG000 vs OG001","p":"<.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":119,"countries":["United States","Argentina","Brazil","Canada","India","Ireland","Italy","Lebanon","Malaysia","Mexico","Sweden","United Kingdom"]},"refs":{"pmids":["31540867","31897524","39963952","37178435","32827435"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":18,"n":392},"commonTop":["Nausea","Diarrhoea","Vomiting","Headache","Nasopharyngitis"]}}